Common anti-cancer therapies induce somatic mutations in stem cells of healthy tissue
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Common anti-cancer therapies induce somatic mutations in stem cells of healthy tissue ; volume:13 ; number:1 ; day:7 ; month:10 ; year:2022 ; pages:1-10 ; date:12.2022
Nature Communications ; 13, Heft 1 (7.10.2022), 1-10, 12.2022
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-022-33663-5
- URN
-
urn:nbn:de:101:1-2022122321185538818361
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kuijk, Ewart
- Kranenburg, Onno
- Cuppen, Edwin
- Van Hoeck, Arne
- SpringerLink (Online service)
Ähnliche Objekte (12)
Mouse APOBEC1 cytidine deaminase can induce somatic mutations in chromosomal DNA
Somatic mutations in cancer development
Somatic mutations in primary melanoma tumors
Somatic genetic mutations in urogenital tumors
Somatic evolutionary timings of driver mutations
Development of novel parvovirus-based anticancer therapies
Optimization of personalized therapies for anticancer treatment
Erratum to: Somatic mutations in cancer development
Domain landscapes of somatic mutations in cancer
Somatic activating mutations in MAP2K1 cause melorheostosis
Assessing the economic value of anti-cancer therapies
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma
Mouse APOBEC1 cytidine deaminase can induce somatic mutations in chromosomal DNA
Somatic mutations in cancer development
Somatic mutations in primary melanoma tumors
Somatic genetic mutations in urogenital tumors
Somatic evolutionary timings of driver mutations
Development of novel parvovirus-based anticancer therapies
Optimization of personalized therapies for anticancer treatment
Erratum to: Somatic mutations in cancer development
Domain landscapes of somatic mutations in cancer
Somatic activating mutations in MAP2K1 cause melorheostosis
Assessing the economic value of anti-cancer therapies
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma
Mouse APOBEC1 cytidine deaminase can induce somatic mutations in chromosomal DNA
Somatic mutations in cancer development
Somatic mutations in primary melanoma tumors
Somatic genetic mutations in urogenital tumors
Somatic evolutionary timings of driver mutations
Development of novel parvovirus-based anticancer therapies
Optimization of personalized therapies for anticancer treatment
Erratum to: Somatic mutations in cancer development
Domain landscapes of somatic mutations in cancer
Somatic activating mutations in MAP2K1 cause melorheostosis
Assessing the economic value of anti-cancer therapies